Clinical Treatment and Prognosis of Breast Cancer
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 July 2026 | Viewed by 391
Special Issue Editors
Interests: cell biology; molecular biology; biomarkers
Special Issues, Collections and Topics in MDPI journals
2. Clinic of Obstetrics and Gynecology, Klinikum Freudenstadt, 72250 Freudenstadt, Germany
Interests: breast cancer; therapy; personalized therapy; gynecologic oncology; gynecologic cancers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to the upcoming Special Issue Clinical Treatment and Prognosis of Breast Cancer. This Issue aims to bring together high-quality research and clinical insights that advance our understanding of modern breast cancer therapies, personalized treatment strategies, prognosis, survival and long-term patient outcomes.
Breast cancer remains one of the most common and complex malignancies worldwide, and continuous innovation in its treatment is essential. We welcome original research articles, comprehensive reviews, and clinical case studies that explore novel treatment approaches, predictive biomarkers, surgical techniques, patient management, and emerging therapies.
Our goal is to create a multidisciplinary platform for exchanging knowledge that can influence current practices and future directions in oncology. Your expertise and clinical experience would make a valuable contribution to this Special Issue.
We look forward to receiving your submissions and to collaborating on this important topic that affects millions globally.
With best regards,
Dr. Roxana Popescu
Dr. Ionut Marcel Cobec
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- targeted therapy
- personalized therapy
- alternative approach
- tumor biology
- gynecologic oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
